Oral secretory leukocyte protease inhibitor (SLPI): Associations with oropharyngeal cancer and treatment outcome

ConclusionsSalivary SLPI was not associated with OPC risk but was associated with higher odds of an incomplete treatment response.

Source: PLoS One - July 2, 2021 Category: Biomedical Science Authors: Brittney L. Dickey Source Type: research